The IFNA family is released by almost all cell types and a few of the human family members, specifically human IFNA2a and IFNA2b, are currently approved for treatment of a range of viral diseases including hepatitis B and C, condylomata acuminate (genital warts), and AIDS-related Kaposi sarcoma (12). This evidence concerns the gene IFNA1 and viral infectious disease.